drugset / Trial / NCT00690092

A Multi-center Study of Spherule-Derived Coccidioidin

NCT00690092 ↗

RandomizedParallel-groupTriple-blindDiagnostic

Summary

Adult volunteers were skin tested with 1.27 ug spherule-derived coccidioidin. The skin test antigen was evaluated in three different populations of adult volunteers to determine the safety and efficacy of the product in the assessment of delayed-type hypersensitivity to Coccidioides immitis. Induration greater than or equal to 5 mm after 48 hours was considered positive for exposure to C. immitis.

Timeline

Start
2005-05
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Spherule-derived coccidioidin Unknown 1.27 ug Other

Indications